| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |